Bio-Techne CorpBio-Techne CorpBio-Techne Corp

Bio-Techne Corp

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪13.00 B‬USD
‪285.19 M‬USD
‪1.14 B‬USD
‪155.96 M‬
Beta (1Y)

About Bio-Techne Corp

Kim Kelderman
Employees (FY)
‪3.05 K‬
Bio-Techne Corp. engages in the development, manufacture and sale of biotechnology reagents and instruments for the research and clinical diagnostic markets. It operates through the Protein Sciences, and Diagnostics and Genomics segments. The Protein Sciences segment develops and manufactures purified proteins, and reagent solutions. The Diagnostics and Genomics segment develops and manufactures diagnostic products. The company was founded in 1976 and is headquartered in Minneapolis, MN.
Revenue to profit conversion
Debt level and coverage

See all ideas 

Summarizing what the indicators are suggesting.
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Curated watchlists where TECH is featured.

Frequently Asked Questions

The current price of TECH is 82.68 USD — it has increased by 0.22% in the past 24 hours. Watch Bio-Techne Corp stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Bio-Techne Corp stocks are traded under the ticker TECH.
TECH stock has risen by 0.33% compared to the previous week, the month change is a 32.39% rise, over the last year Bio-Techne Corp has showed a 1.37% decrease.
We've gathered analysts' opinions on Bio-Techne Corp future price: according to them, TECH price has a max estimate of 95.00 USD and a min estimate of 65.00 USD. Watch TECH chart and read a more detailed Bio-Techne Corp stock forecast: see what analysts think of Bio-Techne Corp and suggest that you do with its stocks.
TECH reached its all-time high on Sep 23, 2021 with the price of 135.96 USD, and its all-time low was 0.08 USD and was reached on May 17, 1989. View more price dynamics on TECH chart.
See other stocks reaching their highest and lowest prices.
TECH stock is 3.18% volatile and has beta coefficient of 1.33. Track Bio-Techne Corp stock price on the chart and check out the list of the most volatile stocks — is Bio-Techne Corp there?
Today Bio-Techne Corp has the market capitalization of ‪13.00 B‬, it has increased by 19.81% over the last week.
Yes, you can track Bio-Techne Corp financials in yearly and quarterly reports right on TradingView.
Bio-Techne Corp is going to release the next earnings report on Aug 6, 2024. Keep track of upcoming events with our Earnings Calendar.
TECH earnings for the last quarter are 0.48 USD per share, whereas the estimation was 0.45 USD resulting in a 6.01% surprise. The estimated earnings for the next quarter are 0.50 USD per share. See more details about Bio-Techne Corp earnings.
Bio-Techne Corp revenue for the last quarter amounts to ‪303.43 M‬ USD despite the estimated figure of ‪292.15 M‬ USD. In the next quarter revenue is expected to reach ‪306.34 M‬ USD.
TECH net income for the last quarter is ‪49.05 M‬ USD, while the quarter before that showed ‪27.46 M‬ USD of net income which accounts for 78.63% change. Track more Bio-Techne Corp financial stats to get the full picture.
Yes, TECH dividends are paid quarterly. The last dividend per share was 0.08 USD. As of today, Dividend Yield (TTM)% is 0.39%. Tracking Bio-Techne Corp dividends might help you take more informed decisions.
Bio-Techne Corp dividend yield was 0.39% in 2023, and payout ratio reached 18.16%. The year before the numbers were 0.37% and 19.31% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of May 22, 2024, the company has ‪3.05 K‬ employees. See our rating of the largest employees — is Bio-Techne Corp on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Bio-Techne Corp EBITDA is ‪363.54 M‬ USD, and current EBITDA margin is 34.13%. See more stats in Bio-Techne Corp financial statements.
Like other stocks, TECH shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Bio-Techne Corp stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Bio-Techne Corp technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Bio-Techne Corp stock shows the strong buy signal. See more of Bio-Techne Corp technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.